Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NOVARTIND.NSE
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Novartis India Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Market cap
- 16.60B
- Ent value
- -
- Price/Sales
- 5.03
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 17.38
- Forward P/E
- -
- PEG
- -
- EPS growth
- 8.05%
- 1 year return
- -0.08%
- 3 year return
- 2.86%
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
NOVARTIND.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 17.38 |
| Price to OCF | 4256.00 |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 5.03 |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 24.69M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.30B |
| Gross profit (TTM) | 1.41B |
| Operating income (TTM) | 925.60M |
| Net income (TTM) | 955.30M |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 42.73% |
| Operating margin (TTM) | 28.05% |
| Profit margin (TTM) | 28.95% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 398.00M |
| Net receivables | 438.20M |
| Total current assets | 5.97B |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 78.30M |
| Total assets | 8.71B |
| Accounts payable | 435.70M |
| Short/Current long term debt | 82.60M |
| Total current liabilities | 1.39B |
| Total liabilities | 1.68B |
| Shareholder's equity | 7.02B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 3.90M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 0.00 |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| NOVARTIND.NSE | S&P500 | |
| Current price drop from All-time high | -35.91% | -4.80% |
| Highest price drop | -46.93% | -56.47% |
| Date of highest drop | 20 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -26.71% | -11.07% |
| Avg time to new high | 98 days | 12 days |
| Max time to new high | 595 days | 1805 days |
COMPANY DETAILS
Marketcap
16.60B
Marketcap category
Large-cap
Description
Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
Employees
67
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found